REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Venomed Sp. z o.o. (Poland)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Pharmacies and Drug Stores | Research and Development in Biotechnology (except Nanobiotechnology) | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Offices of Physicians | Offices of Dentists | Offices of All Other Miscellaneous Health Practitioners | All Other Miscellaneous Ambulatory Health Care Services | General Medical and Surgical Hospitals
Full name: Venomed Sp. z o.o. Profile Updated: May 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Venomed Sp. z o.o. is a company based in Poland, with its head office in Lodz. The enterprise operates in the Ambulatory Health Care Services industry. It was established on November 06, 2019. From the latest financial highlights, Venomed Sp. z o.o. reported a net sales revenue increase of 30.85% in 2023. Its total assets grew by 101.2% over the same period. In, 2023, the company’s net profit margin increased by 2.61%.

Headquarters
Ul. Jana Matejki 7
Lodz; Lodzkie; Postal Code: 91-402

Contact Details: Purchase the Venomed Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Venomed Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Venomed Sp. z o.o. report to view the information.
Incorporation Date:
November 06, 2019
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Venomed Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
30.85%▲
Total operating revenue
30.81%▲
Operating profit (EBIT)
69.48%▲
Net Profit (Loss) for the Period
73.07%▲
Total assets
101.2%▲
Total equity
122.9%▲
Operating Profit Margin (ROS)
2.59%▲
Net Profit Margin
2.61%▲
Return on Equity (ROE)
-15.88%▼
Quick Ratio
0.12%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo